Clinical Trial Update: Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201 [Phase 1]

View source ↗

Summary

Phase 1 clinical study evaluating the safety and anti-tumor activity of AB-201 in patients with gastric cancer; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• AB-201

Snippet

Sponsor: Yonsei University | Conditions: Malignant Neoplasm of Stomach, Unspecified | Phase 1 | Status: NOT_YET_RECRUITING